Home > Healthcare & Medical Devices > ENT Devices Market

ENT Devices Market Size By Product Type (Diagnostic Ear, Nose, And Throat (ENT) Devices [Rigid Endoscopes {Rhinoscopes, Laryngoscopes, Otological Endoscopes}, Flexible Endoscopes, Robot Assisted Endoscope, Hearing Screening Device], Surgical Ear, Nose, And Throat (ENT) Devices [Radiofrequency Handpieces, Powered Surgical Instrument, Otological Drill Burrs, ENT Hand Instruments, Tympanostomy Tubes, Sinus Dilation Devices, Nasal Packing Devices], Hearing Aids {In-The-Ear (ITE), Receiver ITE, Behind-The-Ear, Canal Hearing Aids ITC, CIC, IIC}, Hearing Implants {Auditory Brainstem Implants, Cochlear Implants, Middle Ear Implants, Bone Anchored Hearing System}, Voice Prosthesis Devices, Nasal Splints {Internal Nasal Splints, External Nasal Splints}), By End-use (Hospitals, Ambulatory Surgical Centers, ENT Clinics, Homecare) Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 – 2030

  • Report ID: GMI496
  • Published Date: May 2022
  • Report Format: PDF

Industry Overview

ENT Devices Market size surpassed USD 18 billion in 2021 and is expected to witness 7.7% CAGR from 2022 to 2030. Growing ENT problems in adults as well as geriatric population is a major factor driving the global demand for ENT devices. For instance, according to the WHO report, by year 2050, approximately 2.5 billion people are predicted to have hearing loss. Out of this number, around 700 million people are anticipated to require hearing rehabilitation. Additionally, favourable reimbursement for ENT procedures and funding policies will drive the overall industry demand.
 

ENT Devices Market

Get more details on this report - Request Free Sample PDF
 

The global outbreak of COVID-19 rendered a negative impact on ENT devices market growth. Movement restrictions and lockdowns have been implemented in many parts of the world by the respective governments. Moreover, several non-essential surgeries were also at halt, to manage the COVID-19 patients. These stringent measures have negatively impacted the market.
 

ENT devices are essential tools for the treatment of a variety of ear, nose and throat disorders. The reliability and accuracy of these devices is crucial owing to the complexity of the organ and its critical location. Some ENT devices are equipped with imaging technology that improves the display of anatomical structures and thereby reduce the risk of associated damages.
 

Technological advancements in ENT devices will boost the industry growth over the analysis period

Technological advancements in hearing aids and ENT gadgets will propel the market growth. Recently developed hearing devices are available in small sizes, that connected to ear by thin invisible tubes. The miniaturization proves beneficial for the industry growth, as it minimizes the social stigma associated with hearing loss in adults and teenagers. Also, some hearing aids devices are equipped with artificial intelligence (AI), that offers to access a deep neural network to process sound.
 

Companies such as Starkey have launched hearing aid devices integrated with AI technology. For instance, company’s device Livio AI has some great features. The hearing aids include a built-in fitness tracker, brain tracking to detect early dementia risk signals, and even a personal assistant to assist with activities such as reminders and transcriptions.
 

Furthermore, advanced exceptional surgical device and gadgets developed by key market players will have positive impact on the market expansion. For instance, Medtronic has launched advanced ENT surgical tools that include ontological burrs and drills. This are lightweight and provides the power and performance for a various otologic procedures. It also offers accuracy in surgeries. Such, aforementioned factors will positively promote the market statistics.
 

Growing demand for accurate and cost-effective diagnosis will propel the market forecasts

Global ENT Devives Market, By Product Type

Get more details on this report - Request Free Sample PDF
 

The diagnostic ear, nose and throat (ENT) devices segment was valued at USD 4.2 billion in 2021. The diagnostic ear, nose and throat (ENT) devices segment is further divided into flexible endoscopes, robot assisted endoscope, hearing screening device, rigid endoscopes. The demand for diagnostic ear, nose and throat (ENT) devices has increased owing to presence of technologically advanced endoscope.
 

These endoscopes are equipped with high level of flexibility and efficiency compared to traditional diagnostic equipment. Therefore, its demand has increased from physicians for low-cost, accurate and efficient diagnosis.
 

Rising preference for same day surgery will propel the market statistics

Global ENT Devives Market, By End-use

Get more details on this report - Request Free Sample PDF
 

Based on end-use, the ear-nose-throat (ENT) devices market is classified into hospitals, ambulatory surgical centers, ENT clinics and homecare. The ambulatory surgical center segment was valued at around USD 5.2 billion in 2021. ASCs offer patients with same-day surgery options that saves patient and physicians’ time. In addition, affordable treatment options at ASCs and presence of sophisticated healthcare professionals further surges its overall market demand.
 

Moreover, from past few years the demand for multispecialty ambulatory surgical centers is rising because it is convenient for patients to get treatment for various health ailments under one roof. Therefore, above-mentioned aspects prove advantageous for the segmental expansion.
 

High awareness regarding Ear-Nose-Throat Devices in the region will boost the North American market expansion

North America ENT Devices Market, By Country

Get more details on this report - Request Free Sample PDF
 

North America ENT devices market captured over 37% business share in 2021 and is poised to grow substantially during the forthcoming years. High adoption rates of technologically advanced devices are likely to fuel the regional market growth. Also, developed countries have a high awareness of the effects of ENT diseases and the availability of procedures and devices to avoid these effects.
 

Moreover, in the U.S. nearly 45,000 to 60,000 new cases ménière’s disease is diagnosed annually. It is an inner ear disorder that leads to dizzy spells and hearing loss. Furthermore, favorable trade policies and regulations associated with ENT devices, and presence of key market players in the region will drive the market statistics.
 

Innovative strategies by key market players will upsurge growth opportunities in ENT devices business

Some of the prominent players functioning in the ENT devices industry include, Accelerant (Johnson & Johnson), Atos Medical, Boston Scientific, Cochlear Limited, Demant (Oticon), Lumenis Be Ltd, Medtronic, Meril Life Sciences Pvt. Ltd, Narang Medical Limited, PENTAX Medical, Signia, Smith & Nephew, Sonova Group, Starkey, Stryker, Surgiform Innovative Surgical Products, Welch Allyn.  These industry participants are involved in various growth strategies with continued innovations and technology improvements to sustain market competition in ENT devices business.
 

Some of the recent industry developments:

  • In September 2020, Cochlear announced the launch of the cochlear hearing aid check. It is a free online tool that allows adults with hearing aids who struggle to hear to learn. Such initiatives undertaken by helped in strengthening its market position.
     
  • In 2020, William Demant holding A/S announced the launch of the new flagship product Oticon More. This processes and balances the full sound scene to give people with a hearing loss access to all relevant sounds. Such launches helped company in widening its product portfolio and strengthen its overall market position in ENT devices business.
     

The Ear-Nose-Throat (ENT) devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2030, for the following segments:

By Product Type

  • Diagnostic Ear, Nose, And Throat (ENT) Devices 
    • Rigid endoscopes
      • Rhinoscopes
      • Laryngoscopes
      • Otological endoscopes
    • Flexible Endoscopes
    • Robot assisted endoscope
    • Hearing screening device
  • Surgical Ear, Nose, And Throat (ENT) Devices 
    • Radiofrequency handpieces
    • Powered surgical instrument
    • Otological drill burrs
    •  ENT hand instruments
    • Tympanostomy tubes
    • Sinus dilation devices
    • Nasal packing devices
  • Hearing aids 
    • In-the-ear (ITE)
    • Receiver ITE
    • Behind-the-ear
    • Canal hearing aids ITC, CIC, IIC
  • Hearing Implants 
    • Auditory brainstem implants
    • Cochlear implants
    • Middle Ear implants
    • Bone anchored hearing system
  • Nasal Splints 
    • Internal nasal splints
    • External nasal splints
  •  Voice prosthesis devices

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • ENT Clinics
  • Homecare

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • South Africa

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The ear, nose, and throat (ENT) devices industry size had crossed USD 18 billion in 2021 and is poised to record a 7.7% CAGR through 2030 due to the fast-growing geriatric population and the strong presence of favorable reimbursement for procedures and funding policies.

Industry share of diagnostic ear, nose, and throat (ENT) devices had exceeded USD 4.2 billion in 2021 and will expand with the presence of technologically advanced endoscopes to offer a high level of flexibility and efficiency.

The ear, nose and throat market revenue from the ambulatory surgical centers was valued at over USD 5.2 billion in 2021 driven by the presence of sophisticated healthcare professionals and affordable treatment options in these facilities.

North America held more than 37% of the ear, nose, and throat business share in 2021 and will see expansion with the higher adoption rates of technologically advanced devices in the region.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 17
  • Tables & Figures: 239
  • Countries covered: 18
  • Pages: 170

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount